- Published on
Ophthalmology – Allergic Conjunctivitis
Allergic conjunctivitis is an inflammatory condition of the ocular surface caused by hypersensitivity reactions to environmental allergens and is one of the most common eye disorders, affecting up to 40% of the population. It encompasses several subtypes, including seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis (GPC). SAC occurs during specific times of the year, typically related to pollen exposure, while PAC persists year-round due to indoor allergens such as dust mites or animal dander. VKC and AKC are more severe, chronic forms often involving the cornea, and GPC is typically associated with mechanical irritation, such as contact lens wear or ocular prostheses.
The condition is strongly associated with atopic disease, including asthma, eczema, allergic rhinitis, and hay fever, and often occurs in individuals with a personal or family history of these conditions. VKC tends to affect young males in warm climates and often improves after puberty, whereas AKC occurs in older individuals and is associated with atopic dermatitis. GPC is linked to chronic mechanical irritation rather than classic allergy alone. The underlying pathophysiology involves activation of mast cells in response to allergens, leading to release of histamine and other inflammatory mediators. SAC and PAC are primarily type I hypersensitivity reactions, while VKC and AKC involve both type I and type IV hypersensitivity mechanisms.
Patients commonly present with itching, which is the hallmark symptom, along with redness, tearing, burning, photophobia, and watery discharge. SAC symptoms typically correlate with seasonal allergen exposure, while PAC symptoms are more persistent. VKC presents with intense itching and is often bilateral, while AKC may have chronic symptoms with associated eyelid dermatitis. GPC is often associated with contact lens intolerance and mucous discharge. On examination, SAC and PAC show mild conjunctival injection and papillary reactions without large papillae. VKC is characterized by giant papillae on the upper tarsal conjunctiva, limbal thickening, and Trantas’ dots, with possible corneal involvement such as punctate keratopathy or shield ulcers. AKC may show eyelid eczema, papillary hypertrophy, and corneal scarring or pannus. GPC presents with large papillae on the superior tarsal conjunctiva.
Diagnosis is primarily clinical and does not usually require laboratory testing, although conjunctival scrapings may reveal eosinophils. Differential diagnoses include viral conjunctivitis, dry eye disease, blepharitis, contact dermatitis, toxic or chemical conjunctivitis, and floppy eyelid syndrome. Management focuses on allergen avoidance and symptom control. First-line treatment for mild cases includes topical antihistamines, mast cell stabilizers, or combination agents such as olopatadine or ketotifen. Artificial tears can help dilute allergens and soothe the ocular surface. In more severe cases, especially VKC and AKC, topical corticosteroids may be required but should be used cautiously due to potential side effects such as glaucoma, cataract formation, and increased risk of infection. Topical cyclosporine may be used in chronic or steroid-dependent cases.
For GPC, management includes improving contact lens hygiene, reducing lens wear, or temporarily discontinuing lens use. Additional supportive measures include avoiding known triggers, staying in cool environments, and using preservative-free artificial tears frequently. Patients with significant corneal involvement or vision-threatening complications should be referred to an ophthalmologist for specialized care. Surgical interventions, such as superficial keratectomy or tarsorrhaphy, may be required in severe refractory cases.
The prognosis is generally good for SAC, PAC, and GPC, with symptoms being manageable and often intermittent. However, VKC and AKC can have a more guarded prognosis due to potential corneal complications, including scarring and vision loss. Regular follow-up is important in these cases, particularly when using topical steroids, to monitor intraocular pressure and lens clarity.
Allergic conjunctivitis is an inflammatory condition of the ocular surface caused by hypersensitivity reactions to environmental allergens and is one of the most common eye disorders, affecting up to 40% of the population. It encompasses several subtypes, including seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis (GPC). SAC occurs during specific times of the year, typically related to pollen exposure, while PAC persists year-round due to indoor allergens such as dust mites or animal dander. VKC and AKC are more severe, chronic forms often involving the cornea, and GPC is typically associated with mechanical irritation, such as contact lens wear or ocular prostheses.
The condition is strongly associated with atopic disease, including asthma, eczema, allergic rhinitis, and hay fever, and often occurs in individuals with a personal or family history of these conditions. VKC tends to affect young males in warm climates and often improves after puberty, whereas AKC occurs in older individuals and is associated with atopic dermatitis. GPC is linked to chronic mechanical irritation rather than classic allergy alone. The underlying pathophysiology involves activation of mast cells in response to allergens, leading to release of histamine and other inflammatory mediators. SAC and PAC are primarily type I hypersensitivity reactions, while VKC and AKC involve both type I and type IV hypersensitivity mechanisms.
Patients commonly present with itching, which is the hallmark symptom, along with redness, tearing, burning, photophobia, and watery discharge. SAC symptoms typically correlate with seasonal allergen exposure, while PAC symptoms are more persistent. VKC presents with intense itching and is often bilateral, while AKC may have chronic symptoms with associated eyelid dermatitis. GPC is often associated with contact lens intolerance and mucous discharge. On examination, SAC and PAC show mild conjunctival injection and papillary reactions without large papillae. VKC is characterized by giant papillae on the upper tarsal conjunctiva, limbal thickening, and Trantas’ dots, with possible corneal involvement such as punctate keratopathy or shield ulcers. AKC may show eyelid eczema, papillary hypertrophy, and corneal scarring or pannus. GPC presents with large papillae on the superior tarsal conjunctiva.
Diagnosis is primarily clinical and does not usually require laboratory testing, although conjunctival scrapings may reveal eosinophils. Differential diagnoses include viral conjunctivitis, dry eye disease, blepharitis, contact dermatitis, toxic or chemical conjunctivitis, and floppy eyelid syndrome. Management focuses on allergen avoidance and symptom control. First-line treatment for mild cases includes topical antihistamines, mast cell stabilizers, or combination agents such as olopatadine or ketotifen. Artificial tears can help dilute allergens and soothe the ocular surface. In more severe cases, especially VKC and AKC, topical corticosteroids may be required but should be used cautiously due to potential side effects such as glaucoma, cataract formation, and increased risk of infection. Topical cyclosporine may be used in chronic or steroid-dependent cases.
For GPC, management includes improving contact lens hygiene, reducing lens wear, or temporarily discontinuing lens use. Additional supportive measures include avoiding known triggers, staying in cool environments, and using preservative-free artificial tears frequently. Patients with significant corneal involvement or vision-threatening complications should be referred to an ophthalmologist for specialized care. Surgical interventions, such as superficial keratectomy or tarsorrhaphy, may be required in severe refractory cases.
The prognosis is generally good for SAC, PAC, and GPC, with symptoms being manageable and often intermittent. However, VKC and AKC can have a more guarded prognosis due to potential corneal complications, including scarring and vision loss. Regular follow-up is important in these cases, particularly when using topical steroids, to monitor intraocular pressure and lens clarity.
0 Comments
